European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease

SCOPE: Despite the large availability of vaccines, coronavirus disease 2019 (COVID-19), induced by severe acute respiratory syndrome coronavirus 2, continues to be a major threat for health-care providers and fragile people. A number of options are now available for outpatients with mild-to-moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartoletti, Michele, Azap, Ozlem, Barac, Aleksandra, Bussini, Linda, Ergonul, Onder, Krause, Robert, Martin-Quiros, Alejandro, Paño-Pardo, José Ramón, Power, Nicholas, Sibani, Marcella, Szabo, Balint Gergely, Tsiodras, Sotirios, Zollner-Schwetz, Ines, Rodríguez-Baño, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398787/
https://www.ncbi.nlm.nih.gov/pubmed/36028088
http://dx.doi.org/10.1016/j.cmi.2022.08.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398787/
https://www.ncbi.nlm.nih.gov/pubmed/36028088
http://dx.doi.org/10.1016/j.cmi.2022.08.013

Ejemplares similares